Search research articles
Contact Us
Filters
Showing results (251-260 of 264) with videos related to
Page
of 27
Sort By:
Bioorganic & Medicinal Chemistry
|
September 1, 1993
Double bond isosteres of the peptide bond: synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs
Y K Shue, M D Tufano, G M Carrera, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
May 21, 2003
In vitro pharmacological properties of two novel non-imidazole H3 receptor (H3R) antagonists
B B Yao, D G Witte, T R Miller, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
September 7, 2007
A new family of histamine H3 receptor antagonists based on a natural product: discovery, SAR, and properties of the series
M Cowart, M Sun, C Zhao, et al.
Journal of Medicinal Chemistry
|
May 27, 1994
Novel Asp32-replacement tetrapeptide analogues as potent and selective CCK-A agonists
R L Elliott, H Kopecka, M D Tufano, et al.
Journal of Medicinal Chemistry
|
August 7, 1992
Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo
M W Holladay, M J Bennett, M D Tufano, et al.
The American Review of Respiratory Disease
|
December 1, 1993
Upper and middle lobe bronchoalveolar lavage to diagnose Pneumocystis carinii pneumonia
R C Yung, A B Weinacker, D J Steiger, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
March 18, 2008
Minimization of potential hERG liability in histamine H3 receptor antagonists
L A Black, H Liu, G J Diaz, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
June 2, 2005
Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology
T A Esbenshade, B B Yao, D G Witte, et al.
Neuropharmacology
|
December 1, 2005
Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor
B Bei Yao, D G Witte, T R Miller, et al.
Hormone Research
|
December 5, 1998
Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein
K Loh, K K Matthay, M Hoover, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 264) with videos related to
Sort By:
Page
of 27
Bioorganic & Medicinal Chemistry
|
September 1, 1993
Double bond isosteres of the peptide bond: synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs
Y K Shue, M D Tufano, G M Carrera, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
May 21, 2003
In vitro pharmacological properties of two novel non-imidazole H3 receptor (H3R) antagonists
B B Yao, D G Witte, T R Miller, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
September 7, 2007
A new family of histamine H3 receptor antagonists based on a natural product: discovery, SAR, and properties of the series
M Cowart, M Sun, C Zhao, et al.
Journal of Medicinal Chemistry
|
May 27, 1994
Novel Asp32-replacement tetrapeptide analogues as potent and selective CCK-A agonists
R L Elliott, H Kopecka, M D Tufano, et al.
Journal of Medicinal Chemistry
|
August 7, 1992
Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo
M W Holladay, M J Bennett, M D Tufano, et al.
The American Review of Respiratory Disease
|
December 1, 1993
Upper and middle lobe bronchoalveolar lavage to diagnose Pneumocystis carinii pneumonia
R C Yung, A B Weinacker, D J Steiger, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
March 18, 2008
Minimization of potential hERG liability in histamine H3 receptor antagonists
L A Black, H Liu, G J Diaz, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
June 2, 2005
Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology
T A Esbenshade, B B Yao, D G Witte, et al.
Neuropharmacology
|
December 1, 2005
Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor
B Bei Yao, D G Witte, T R Miller, et al.
Hormone Research
|
December 5, 1998
Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein
K Loh, K K Matthay, M Hoover, et al.
Page
of 27